Tango Therapeutics Inc.
Organization details
- Legal name
- Tango Therapeutics Inc.
- Former names
- BCTG Acquisition Corp.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TNGX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001819133
- Wikidata ID
- Q106411720
Board of directors
-
Aaron I. Davis · DirectorSince 2023
- Since 2023
-
Barbara Weber · Director · Director, Executive ChairSince 2023
-
John B. Ketchum · DirectorSince 2023
-
Joseph Lewis · DirectorSince 2023
-
Kanishka Pothula · DirectorSince 2023
-
Lesley Ann Calhoun · DirectorSince 2023
-
Mace Rothenberg · DirectorSince 2023
-
Malte Peters · Director · President & CEOSince 2023
-
Reid M. Huber · DirectorSince 2023
-
Robert Azelby · DirectorSince 2026
-
Sung Lee · DirectorSince 2026
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
79.9%
-
84.8%
Board connections
5 of this board's directors also sit on 9 other boards. 9 are in the same sector.
-
Parabilis Medicines Inc. Same sectorvia Alexis Borisy and Barbara Weber
-
Revolution Medicines Inc. Same sectorvia Alexis Borisy and Barbara Weber
-
ADC Therapeutics SA Same sectorvia Robert Azelby
- via Robert Azelby
-
Cardinal Health Inc. Same sectorvia Robert Azelby
-
OPKO Health Inc. Same sectorvia Alexis Borisy
-
Rapport Therapeutics Inc. Same sectorvia Reid M. Huber
-
Relay Therapeutics Inc. Same sectorvia Alexis Borisy
-
Surrozen Inc. Same sectorvia Mace Rothenberg
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $7,958,481
- 29 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Crystal Adam Officer (President, R&D) | Option exercise | +5,000 | $2.91 | $14,550 |
| Nov 2, 2026 | Newcomb Jessica Officer (Principal Accounting Officer) | Open-market sale | −5,571 | $22.28 | $124,107 |
| Nov 2, 2026 | Crystal Adam Officer (President, R&D) | Open-market sale | −3,900 | $22.26 | $86,821 |
| Nov 2, 2026 | Newcomb Jessica Officer (Principal Accounting Officer) | Open-market sale | −1,460 | $22.98 | $33,553 |
| Nov 2, 2026 | Crystal Adam Officer (President, R&D) | Open-market sale | −1,100 | $22.99 | $25,287 |
| Oct 1, 2026 | Crystal Adam Officer (President, R&D) | Option exercise | +27,000 | $5.20 | $140,400 |
| Oct 1, 2026 | Crystal Adam Officer (President, R&D) | Open-market sale | −26,400 | $24.45 | $645,604 |
| Oct 1, 2026 | Crystal Adam Officer (President, R&D) | Open-market sale | −600 | $25.32 | $15,192 |
| Sep 22, 2026 | Newcomb Jessica Officer (Principal Accounting Officer) | Open-market sale | −700 | $22.80 | $15,960 |
| Sep 22, 2026 | Newcomb Jessica Officer (Principal Accounting Officer) | Open-market sale | −5,100 | $23.97 | $122,247 |
| Sep 22, 2026 | Newcomb Jessica Officer (Principal Accounting Officer) | Open-market sale | −2,400 | $25.17 | $60,408 |
| Sep 1, 2026 | Crystal Adam Officer (President, R&D) | Option exercise | +27,000 | $5.20 | $140,400 |
| Sep 1, 2026 | Crystal Adam Officer (President, R&D) | Open-market sale | −27,000 | $22.37 | $603,990 |
| Aug 3, 2026 | Crystal Adam Officer (President, R&D) | Option exercise | +27,000 | $5.20 | $140,400 |
| Aug 3, 2026 | Crystal Adam Officer (President, R&D) | Open-market sale | −5,267 | $26.79 | $141,103 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Tango Therapeutics Inc.
Who is the CEO of Tango Therapeutics Inc.?
Barbara Weber is Tango Therapeutics Inc.'s Chief Executive Officer.
How many directors are on Tango Therapeutics Inc.'s board?
Tango Therapeutics Inc.'s board has 12 directors: Aaron I. Davis, Alexis Borisy, Barbara Weber, John B. Ketchum, Joseph Lewis, Kanishka Pothula, Lesley Ann Calhoun, Mace Rothenberg, Malte Peters, Reid M. Huber and 2 others.
Are Tango Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Tango Therapeutics Inc. insiders made no open-market purchases and sold $8.0 million of shares in 29 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="tango-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.